Latest VTR news and sentiment

Why Ventas (VTR) is a Top Dividend Stock for Your Portfolio

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments. Cash flow can come from bond interest, interest from other types of investments, and, of course, dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock price. Many academic

Bank of America Corp DE Makes New $390.39 Million Investment in Ventas, Inc. $VTR

Bank of America Corp DE has made a significant new investment of $390.39 million in Ventas, Inc. (NYSE:VTR), acquiring approximately 0.86% of the healthcare REIT. This move comes as Ventas continues to perform well, exceeding quarterly earnings and revenue expectations, and maintaining a "Moderate Buy" consensus rating from analysts. The company also declared a quarterly dividend of $0.52, highlighting its financial health and appeal to institutional investors.

Ventas, Inc. Announces Appointment of Laurida Sayed as Senior Vice President, Chief Accounting Officer and Controller, Effective on or About October 5, 2026

Ventas, Inc. has announced the appointment of Laurida Sayed as its Senior Vice President, Chief Accounting Officer, and Controller, effective around October 5, 2026. Ms. Sayed previously served as Chief Accounting Officer at Cushman & Wakefield Ltd. and brings extensive experience in global corporate control and finance transformation. She is a Certified Public Accountant with a Bachelor of Business Administration in Accounting.

HighTower Advisors LLC Has $5.10 Million Holdings in Ventas, Inc. $VTR

HighTower Advisors LLC reduced its stake in Ventas, Inc. by 29.4% in the second quarter, bringing its total holdings to $5.10 million. Despite this reduction, Ventas continues to see significant institutional investment, with 94.18% of its stock owned by institutional investors and hedge funds. Analyst ratings for Ventas are largely positive, with a consensus "Moderate Buy" rating and an average price target of $99.00.

Ventas Acquires Sierra Del Sol Senior Living in Tucson for $14.96 Million

Ventas, Inc., a prominent healthcare REIT, has acquired the Sierra Del Sol Assisted Living | Memory Care and Respite Care facility in Tucson, Arizona, for $14.96 million. The property, with 135 units and 140 beds, was purchased from an affiliate of Kohlberg Kravis Roberts & Co. This acquisition expands Ventas's healthcare real estate portfolio and represents a significant increase in value from its previous sale in 2018.

Ventas, Inc. acquired Arbor Village from KKR & Co. Inc. for $24.1 million.

Ventas, Inc. acquired Arbor Village from KKR & Co. Inc. for $24.1 million on September 9, 2026. This valuation is based on industry speculation from excise tax affidavit records in King County. The transaction involved a cash consideration of $24.08 million.

Ventas Inc. stock holds steady as institutional investors build positions

Louisville health care and political giant Bruce Lunsford dies at 78

Bruce Lunsford, a prominent figure in Kentucky's healthcare and political landscape, has passed away at the age of 78. He was known for building Vencor into a leading long-term healthcare provider and founding Ventas Inc. Lunsford also served as Kentucky's first secretary of commerce.

Nykredit A S Invests $11.70 Million in Ventas, Inc. $VTR

Nykredit A S has acquired a new stake worth approximately $11.70 million in Ventas, Inc. (NYSE:VTR) during the second quarter. Other institutional investors like Deutsche Bank AG, Bank of New York Mellon Corp, and Norges Bank also adjusted their holdings in the healthcare REIT. Analysts currently rate Ventas with a "Moderate Buy" and a consensus price target of $99.00.

Precision Trading with Ventas Inc. (VTR) Risk Zones

This article provides a detailed analysis of Ventas Inc. (VTR) using AI-generated signals for precision trading. It highlights weak near-term sentiment that could challenge long-term strength, an exceptional 22.7:1 risk-reward short setup, and divergent sentiment across various time horizons. The analysis includes three distinct trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for different risk profiles, along with multi-timeframe signal analysis indicating support and resistance levels.

Ventas (VTR) is a Top Dividend Stock Right Now: Should You Buy?

All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But when you're an income investor, your primary focus is generating consistent cash flow from each of your liquid investments. While cash flow can come from bond interest or interest from other types of investments, income investors hone in on dividends. A dividend is that coveted distribution of a company's earnings paid out to shareholders, and investors often view it by its dividend yield, a metric that measures the dividend as a percent of the current stock

Scotiabank Adjusts Price Target on Ventas to $95 From $93, Maintains Sector Perform Rating

Barclays Remains a Hold on Ventas (VTR)

Barclays maintained a Hold rating on Ventas (VTR) with a $102.00 price target, following a report from analyst Richard Hightower. The company reported a quarterly revenue of $1.73 billion and a net profit of $74.11 million for the quarter ending June 30. Corporate insider sentiment is positive, with an increase in insider buying over the past quarter, including a recent purchase by director Michael Embler.